← Leaderboards
Brian C-H Chiu
University Of Nebraska Medical Center
$5,770,494
Attributed
$9,952,595
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,952,595 · 12
By mechanism
R01$6,227,501 · 3
R33$1,181,771 · 1
R21$884,588 · 2
P30$792,350 · 1
R03$566,392 · 4
R56$299,993 · 1
Top collaborators
- Wei Zhang16 shared
- Benjamin Derman3 shared
- Andrew M Evens3 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Kenneth Cowan$25,385,222
- J. Alan Diehl$22,210,909
- Craig Semerad$656,961
- Raymond C Bergan$7,632,509
- Robert S Lahue$2,704,744
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMalignant NeoplasmsInnovationSamplingBaseDiagnosisHematologic NeoplasmsMultiple MyelomaEpigenetic ProcessMortalityTumorBiologicalMissionPublic HealthPlasma CellsModificationResourcesRelapseCellsProgramsResidual NeoplasmPathogenesisNext Generation SequencingResearch Project Grants
Grant awards (34)
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma$654,367
R01 · FY2025 · CA · contact PI
RNA m6A modifications and treatment response in multiple myeloma$188,244
R21 · FY2025 · CA · contact PI
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma$631,736
R01 · FY2024 · CA · contact PI
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research$370,741
R33 · FY2024 · CA · contact PI
RNA m6A modifications and treatment response in multiple myeloma$241,585
R21 · FY2024 · CA · contact PI
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma$691,734
R01 · FY2023 · CA · contact PI
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research$389,864
R33 · FY2023 · CA · contact PI
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities$299,993
R56 · FY2023 · CA · contact PI
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma$609,211
R01 · FY2022 · CA · contact PI
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research$421,166
R33 · FY2022 · CA · contact PI
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma$634,955
R01 · FY2021 · CA · contact PI
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma$645,738
R01 · FY2020 · CA · contact PI
CACHET: Integrative Health Sciences Facility Core$197,101
P30 · FY2020 · ES · contact PI
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma$635,981
R01 · FY2019 · CA · contact PI
CACHET: Integrative Health Sciences Facility Core$197,101
P30 · FY2019 · ES · contact PI
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myeloma$682,363
R01 · FY2018 · CA · contact PI
Using epigenomic subtyping to understand the racial differences in lymphoma$200,434
R21 · FY2018 · MD · contact PI
CACHET: Integrative Health Sciences Facility Core$194,651
P30 · FY2018 · ES · contact PI
Using epigenomic subtyping to understand the racial differences in lymphoma$254,325
R21 · FY2017 · MD · contact PI
CACHET: Integrative Health Sciences Facility Core$203,497
P30 · FY2017 · ES · contact PI
Lifestyle Factors and Lymphoma: An Asia Cohort Consortium Pooling Project$85,606
R03 · FY2014 · CA · contact PI
Lifestyle Factors and Lymphoma: An Asia Cohort Consortium Pooling Project$100,161
R03 · FY2013 · CA · contact PI
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival$44,975
R03 · FY2010 · CA
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival$32,189
R03 · FY2010 · CA
Lymphoma Defined Cytogenetically for Epidemiologic Study$219,753
R01 · FY2009 · CA · contact PI
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival$75,322
R03 · FY2009 · CA
Lymphoma Defined Cytogenetically for Epidemiologic Study$202,456
R01 · FY2008 · CA · contact PI
Risk Factors for Molecularly Defined Subgroups of Lymphoma: A Pooled Analysis$63,289
R03 · FY2008 · CA · contact PI
Risk Factors for Molecularly Defined Subgroups of Lymphoma: A Pooled Analysis$13,999
R03 · FY2008 · CA · contact PI
Lymphoma Defined Cytogenetically for Epidemiologic Study$195,935
R01 · FY2007 · CA · contact PI
Risk Factors for Molecularly Defined Subgroups of Lymphoma: A Pooled Analysis$77,288
R03 · FY2007 · CA · contact PI
Lymphoma Defined Cytogenetically for Epidemiologic Study$202,553
R01 · FY2006 · CA · contact PI
Lymphoma Defined Cytogenetically for Epidemiologic Study$220,719
R01 · FY2005 · CA
Case-Control Study of Pesticides and t(14;18) Lymphoma$73,563
R03 · FY2002 · CA